Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis.
Manoj KumarRam BajpaiAbdul Rahaman ShaikSwati SrivastavaDivya VohoraPublished in: European journal of clinical pharmacology (2020)
Our findings suggests that SSRIs may be associated with an increased fracture risk; hence, bone health should be taken into consideration while prescribing this class of drugs.